Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-01 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.400 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
IMNM | Immunome | 30.40 | 0.21 | 0.7% | 324.1M |
You can purchase shares of Immunome (NASDAQ: IMNM) through any online brokerage.
There are no as such competitors for Immunome.
The latest price target for Immunome (NASDAQ: IMNM) was reported by Chardan Capital on 2020-10-27. The analyst firm set a price target for 18.00 expecting IMNM to fall to within 12 months (a possible -40.79% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Immunome (NASDAQ: IMNM) is $30.4 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Immunome.
There is no upcoming split for Immunome.